Kidney & Blood Pressure Research (Mar 2022)

Circ_0037866 contributes to the tumorigenesis of renal cell carcinoma by sequestering miR-384 to elevate CBX5 expression

  • Xiaoqiang Shi,
  • Shichao Song,
  • Ying Gao,
  • Zhenyu Cui,
  • Wentao Wang,
  • Mingkai Liu

DOI
https://doi.org/10.1159/000522190

Abstract

Read online

Background: Circular RNAs (circRNAs) were demonstrated to have roles in the carcinogenesis of renal cell carcinoma (RCC). Hence, this work aimed to determine the functions and molecular mechanism of circ_0037866 in regulating the progression of RCC. Methods: Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting were used to detect the levels of genes and proteins. In vitro assays, including colony formation, 5-ethynyl-2’-deoxyuridine (EdU), flow cytometry, transwell assays, and in vivo tumor formation were conducted to investigate the effects of circ_0037866 on RCC tumorignesis. Dual-luciferase reporter assay, RNA-pull down and RIP assay were used to confirm the interaction between miR-384 and circ_0037866 or CBX5 (Chromobox 5). Results: Circ_0037866 is stable circRNA and was found to be increased in RCC tissues and cells. Functionally, circ_0037866 silencing suppressed RCC cell survival, invasion and migration in vitro, and impeded RCC cell tumorigenesis in the subcutaneous xenograft model. Mechanistically, circ_0037866 could function as a sponge for miR-384 to elevate the expression of its target CBX5. Furthermore, a series of rescue experiments showed that miR-384 inhibition reversed the anticancer effects of circ_0037866 knockdown on RCC cells; besides that, miR-384 restoration suppressed RCC cell growth and mobility, which were attenuated by CBX5 overexpression. Conclusion: Circ_0037866 knockdown restrains the tumorigenesis of RCC by miR-384/CBX5, revealing a promising molecular target for RCC therapy.